6505--RFI - DRAFT SOW for PPV 2028
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Department of Veterans Affairs (VA) is conducting an industry review and solicitation of feedback on the draft Statement of Work (SOW) for the Pharmaceutical Prime Vendor (PPV) 2028 acquisition. This effort seeks to engage qualified vendors early in the process to help ensure the final SOW is clear, comprehensive, and structured to facilitate effective competition. The VA invites comments on various aspects including potential ambiguities in requirements, technical and operational details, distribution and inventory management, reporting and data exchange processes, risks, and suggestions for enhancing efficiency and alignment with industry best practices. This participation is voluntary, not a prerequisite for future contract bids, and no contracts will be awarded from this initial request. Respondents are requested to submit their feedback by July 2, 2026, at 11 AM Central Time via email to the designated VA contact, Karen Ade. Submissions should include company details, point of contact information, and relevant identifiers such as UEI and CAGE codes, along with any socioeconomic designations. The VA emphasizes that this notice is not a solicitation and participation will be used solely for market research and refinement of the SOW to support the nationwide delivery of pharmaceutical products to VA medical centers. The government will not cover any costs related to providing feedback, and all input received may be used to revise the SOW and inform future acquisition documents.
General Info
Agency
NAICS
Place of Performance
ILSet-Aside
Timeline
Response Deadline
Organization & Contact Information
Full Description
GENERAL INFORMATION CONTRACTING OFFICE S ZIP CODE 60141 SOLICITATION NUMBER 36W79726Q0001 RESPONSE DATE/TIME/ZONE 07-02-2026 11AM CENTRAL TIME, CHICAGO, USA NAICS CODE 325412 CONTRACTING OFFICE ADDRESS Department of Veterans Affairs National Acquisition Center National Contract Service Bldg 37, PO Box 76 60141 POINT OF CONTACT
Karen Ade Karen.Ade@va.gov 708-786-5231
DESCRIPTION Department of Veterans Affairs Request for Industry Review and Comments on Draft Statement of Work (SOW) Pharmaceutical Prime Vendor (PPV) 2028 The Department of Veterans Affairs (VA) is seeking industry review and feedback on the attached DRAFT Statement of Work (SOW), Definitions and Distribution Fee Categories for the Pharmaceutical Prime Vendor 2028 acquisition. This early engagement is intended to ensure the final SOW is clear, comprehensive and structured to support effective competition from qualified vendors. Industry is invited to provide input including, but not limited to: Identification of unclear, conflicting, or ambiguous requirements Comments on technical or operational requirements that may affect performance Suggestions related to distribution operations, inventory management, reporting, data exchange, or order fulfillment processes Noted risks, barriers, or areas where additional definition would be beneficial Suggestions to improve efficiency, or alignment with industry best practices Industry feedback at this stage helps the VA refine requirements and improve acquisition outcomes. The VA may contact respondents for clarification of submitted comments. Feedback received may be considered in the development of subsequent SOW revisions and acquisition documentation. Participation in this review is voluntary and is not a prerequisite for participation in any future solicitation. Submission Instructions: Provide feedback no later than 11AM Central July 2, 2026 Send responses via email to Karen.Ade@va.gov Include the following in your submission: Company Name Point of contact name, phone and email UEI and CAGE Code Socioeconomic designation(s), if applicable Important Notes: This announcement is not a solicitation and does not obligate the Government to issue a solicitation or award. No contract will be awarded from this notice Participation in this review (or lack thereof) does not preclude any vendor from submitting a proposal to the future PPV 2028 solicitation. All feedback will be used for market research and SOW refinement purposes only. The Government will not reimburse any costs associated with providing comments or participating in any related activities. The VA appreciates industry s time and expertise in supporting the development of a strong, effective SOW for the PPV 2028 program. The VA appreciates industry s participation in helping to shape a clear and effective SOW for the PPV 2028 program, which supports delivery of pharmaceutical products to VA medical centers nationwide.